Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Lerer

Showing results (121-130 of 147) with videos related to

Pageof 15
Sort By:
Molecular Psychiatry|February 21, 2024
Effect of chemically synthesized psilocybin and psychedelic mushroom extract on molecular and metabolic profiles in mouse brainOrr Shahar, Alexander Botvinnik, Amit Shwartz, et al.
Journal of Psychiatric Research|November 14, 2006
Association of the trace amine associated receptor 6 (TAAR6) gene with schizophrenia and bipolar disorder in a Korean case control sampleChi-Un Pae, Hye-Sook Yu, Daniela Amann, et al.
Schizophrenia Research|November 19, 2003
Association of tumor necrosis factor alpha gene -G308A polymorphism with schizophreniaSibylle G Schwab, Stephanie Mondabon, Michael Knapp, et al.
Cancer Letters|April 27, 2023
Corrigendum to "DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancer" [Canc. Lett. 501 224-233]Dotan Moskovich, Adi Alfandari, Yael Finkelshtein, et al.
Cancer Letters|November 22, 2020
DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancerDotan Moskovich, Adi Alfandari, Yael Finkelshtein, et al.
European Journal of Human Genetics : EJHG|April 7, 2005
Fine mapping of a schizophrenia susceptibility locus at chromosome 6q23: increased evidence for linkage and reduced linkage intervalAdi Levi, Yoav Kohn, Kyra Kanyas, et al.
American Journal of Medical Genetics|March 29, 2002
Angiotensin converting enzyme gene insertion/deletion polymorphism: case-control association studies in schizophrenia, major affective disorder, and tardive dyskinesia and a family-based association study in schizophreniaRonnen H Segman, Yami Shapira, Ilan Modai, et al.
European Journal of Human Genetics : EJHG|June 15, 2006
AHI1, a pivotal neurodevelopmental gene, and C6orf217 are associated with susceptibility to schizophreniaDaniela Amann-Zalcenstein, Nili Avidan, Kyra Kanyas, et al.
The International Journal of Neuropsychopharmacology|April 29, 2005
Combined analysis of 635 patients confirms an age-related association of the serotonin 2A receptor gene with tardive dyskinesia and specificity for the non-orofacial subtypeBernard Lerer, Ronnen H Segman, Ene-Choo Tan, et al.
Journal of Psychiatric Research|October 17, 2017
One year double blind study of high vs low frequency subcallosal cingulate stimulation for depressionRenana Eitan, Denys Fontaine, Michel Benoît, et al.
Pageof 15

Showing results (121-130 of 147) with videos related to

Sort By:
Pageof 15
Molecular Psychiatry|February 21, 2024
Effect of chemically synthesized psilocybin and psychedelic mushroom extract on molecular and metabolic profiles in mouse brainOrr Shahar, Alexander Botvinnik, Amit Shwartz, et al.
Journal of Psychiatric Research|November 14, 2006
Association of the trace amine associated receptor 6 (TAAR6) gene with schizophrenia and bipolar disorder in a Korean case control sampleChi-Un Pae, Hye-Sook Yu, Daniela Amann, et al.
Schizophrenia Research|November 19, 2003
Association of tumor necrosis factor alpha gene -G308A polymorphism with schizophreniaSibylle G Schwab, Stephanie Mondabon, Michael Knapp, et al.
Cancer Letters|April 27, 2023
Corrigendum to "DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancer" [Canc. Lett. 501 224-233]Dotan Moskovich, Adi Alfandari, Yael Finkelshtein, et al.
Cancer Letters|November 22, 2020
DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancerDotan Moskovich, Adi Alfandari, Yael Finkelshtein, et al.
European Journal of Human Genetics : EJHG|April 7, 2005
Fine mapping of a schizophrenia susceptibility locus at chromosome 6q23: increased evidence for linkage and reduced linkage intervalAdi Levi, Yoav Kohn, Kyra Kanyas, et al.
American Journal of Medical Genetics|March 29, 2002
Angiotensin converting enzyme gene insertion/deletion polymorphism: case-control association studies in schizophrenia, major affective disorder, and tardive dyskinesia and a family-based association study in schizophreniaRonnen H Segman, Yami Shapira, Ilan Modai, et al.
European Journal of Human Genetics : EJHG|June 15, 2006
AHI1, a pivotal neurodevelopmental gene, and C6orf217 are associated with susceptibility to schizophreniaDaniela Amann-Zalcenstein, Nili Avidan, Kyra Kanyas, et al.
The International Journal of Neuropsychopharmacology|April 29, 2005
Combined analysis of 635 patients confirms an age-related association of the serotonin 2A receptor gene with tardive dyskinesia and specificity for the non-orofacial subtypeBernard Lerer, Ronnen H Segman, Ene-Choo Tan, et al.
Journal of Psychiatric Research|October 17, 2017
One year double blind study of high vs low frequency subcallosal cingulate stimulation for depressionRenana Eitan, Denys Fontaine, Michel Benoît, et al.
Pageof 15